Eye Globe Saved! Professor Chen Zhongping of Changsha Aier Eye Hospital Performs Two Consecutive FCVB Surgeries, Guarding the "Window to the Soul" for Patients with Severe Fundus Diseases
Release time: Apr 29,2026
For patients suffering from severe fundus diseases, repeated surgeries, sudden vision loss and even eye globe atrophy amount to a prolonged battle to save their eyes. The advent of the Foldable Capsular Vitreous Body (FCVB) technology has opened a new door of hope for such patients.
On March 24 and April 21, Professor Chen Zhongping and his fundus disease team from Changsha Aier Eye Hospital successfully performed FCVB implantation surgeries on two patients with complex eye conditions who had undergone multiple previous operations. The advanced technique precisely tackled clinical challenges such as recurrent retinal detachment and silicone oil dependence, preserving the patients’ eye globe structure and ocular dignity with cutting-edge medical technology.
Case One: 31-Year-Old Woman Travels for Medical Treatment for 8 Years; FCVB Preserves Her Last Hope of Saving the Eye Globe
Ms. W, 31, has been plagued by complex fundus disease for eight years. She sought treatment at multiple hospitals and underwent several surgeries, yet failed to get relief from her condition.
Dating back to October 2018, Ms. W was diagnosed with left eye retinal detachment and underwent left eye vitrectomy, membrane peeling, perfluorocarbon liquid injection, laser photocoagulation, cryotherapy, air-fluid exchange and silicone oil tamponade at a local hospital. Hoping for normal recovery after surgery, she soon suffered a series of complications.
In February 2022, she underwent another surgery for left eye uveitis and complicated cataract, including phacoemulsification, intraocular lens implantation, pupilloplasty and anterior chamber plasty. Less than one month after the operation, on February 27, 2022, she received an iridectomy at the root of the iris due to secondary glaucoma in the left eye.
After multiple surgeries, her left eye vision deteriorated to no light perception. Eye examination showed conjunctival congestion, intact sutures, elevated filtering bleb, exudative membrane in the pupillary area, and well-centered intraocular lens. Fundus examination revealed combined retinal and choroidal detachment with early eye globe atrophy, leaving conventional treatments ineffective.
To maintain the normal shape of her eye globe and end her years of medical suffering, Professor Chen Zhongping’s team formulated a personalized FCVB implantation plan. The procedure targeted the core problems of long-term silicone oil dependence and insufficient intraocular support, securing her last chance to preserve the eye globe.
Case Two: 50-Year-Old Man Suffers Recurrence After Multiple Surgeries; FCVB Puts an End to Repeated Treatment
Mr. T, 50, experienced unexplained vision loss in his right eye two years ago, embarking on a long journey of treatment ever since.
In October 2023, he was diagnosed with right eye retinal detachment and received posterior pars plana vitrectomy combined with silicone oil tamponade, which temporarily controlled his condition. However, the relief was short-lived. He underwent silicone oil removal in October 2024. Less than a month after removal, recurrent retinal detachment occurred in November 2024, requiring a second surgery: posterior pars plana vitrectomy, silicone oil tamponade and phacoemulsification for the right eye.
In February 2026, he received another silicone oil removal at a well-known Grade A tertiary hospital. Thinking he had finally recovered, he received bad news during a follow-up check half a month ago: his right eye suffered retinal detachment once again.
His symptoms gradually worsened and seriously affected his daily life. He then came to Changsha Aier Eye Hospital for systematic diagnosis and treatment. Examinations showed clear vitreous in the right eye, with grayish-white elevated retina and signs of eye globe atrophy. Conventional surgeries could no longer control the condition. Without timely intervention, progressive atrophy would eventually lead to the risk of enucleation.
After comprehensive evaluation of his surgical history and current ocular condition, Professor Chen Zhongping’s team decided to perform FCVB implantation. The minimally invasive procedure provides lasting and stable intraocular support for the right eye, prevents recurrent retinal detachment, and effectively preserves the eye globe.
As a pioneer in FCVB surgery since 2021, Sichuan Provincial People’s Hospital has performed this procedure for nearly 20 patients suffering from ocular trauma and silicone oil dependency to safeguard their ocular health with professional expertise. It represents the inheritance and upgrading of the hospital’s diagnostic and treatment technologies, as well as its commitment to delivering high-quality, precise medical services for patients with complex eye diseases.
Compared to conventional surgery, FCB implantation offers significant advantages. The procedure requires only a 4mm conjunctival incision, causes minimal tissue damage, and results in less postoperative pain and faster recovery.
